IL6 and Abdominal obesity: Schrager et al. investigated 378 men and 493 women aged ≥65 years, and reported that central obesity was significantly associated with increased inflammatory biomarkers (IL-6, CRP) which, in turn, negatively affected the muscle strength and contributed to the development and progression of sarcopenic obesity [43].